E-pharmacy Market Size, Share, Trends, Industry Analysis Report: By Drug Type (Prescription Drug, OTC Drug), By Product Type, By Payment Method, By Therapeutic Area, By Business Model, By Platform, and By Region

Description

List of Tables

The global e-pharmacy market size is expected to reach USD 603.06 billion by 2034, according to a new study by Polaris Market Research. The report "E-pharmacy Market Share, Size, Trends, Industry Analysis Report: By Drug Type (Prescription Drugs, and OTC Drugs), By Product Type, By Payment Method, By Platform, By Therapeutic Area, By Business Model, By Region - Market Forecast, 2026-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The e-pharmacy market has witnessed rapid growth in recent years. This growth is driven by the widespread adoption of digital technologies and changing consumer behavior. The E-pharmacies offer the platform through which the consumers can buy their prescription medicines, OTC medicines, health supplements, and personal care items. The e-pharmacy service offers great convenience to the consumers. Preference for online shopping as well as contactless payment systems increases the demand for e-pharmacy service. In addition, the increase in health product availability contributes to the growth of e-pharmacy. Furthermore, the rise in chronic illnesses and geriatric population drives the demand for healthcare services.

The rising adoption of digital healthcare technologies and strong internet connectivity boost the adoption of e-pharmacy platforms. Also, advancements in logistics and delivery have been fueling the growth of the e-pharmacy market. The market opportunity lies in its ability to tap a larger customer base through online channels. In addition, the increasing emphasis on value for money healthcare solutions has led e-pharmacies to offer additional services like telemedicine and home deliveries.

The outlook for the e-pharmacy market looks good, with expectations that the market will continue to grow in the future. There is a rising emphasis on technological advancements and regulatory compliance. It would present great possibilities in the marketplace for both old and new players.

Key Highlights of E-pharmacy Market Report

The OTC drug segment dominated the market with 56.4% revenue share in 2025. This is due to the widespread availability of OTC medicines. The convenience of buying them without a prescription also supports its leading position.

The skin care segment is expected to exhibit a CAGR of 20.6% during the forecast period. Rising consumer awareness of skin health and the increasing popularity of online personal care purchases boost the segment growth.

The online payments segment led with a 62.8% market share in 2025. Its seamless checkout experiences and digital payment adoption drive dominance. Attractive platform incentives have contributed to the growing popularity of online payments.

North America accounted for the largest share of 38.2% in 2025. The dominance is attributed to the surging adoption of online healthcare services and increasing preference for convenient digital pharmacy platforms.

The Asia Pacific e-pharmacy market is expected to register the highest CAGR of 21.7% during the forecast period. The regional market growth is supported by the growing prevalence of common illnesses and rising internet penetration. Expanding access to digital healthcare services also boosts the market penetration.

A few of the key market players are Express Scripts Holding, Giant Eagle, The Walgreen Company, Kroger Co, CVS Health Corporation, DocMorris, PharmEasy, Wal-Mart Stores, OptumRx, Rowland Pharmacy, Lloyds Pharmacy Ltd (McKesson Corporation), Tata 1mg, Netmeds, Apollo Pharmacy, Amazon Pharmacy, Alibaba Health, JD Health, Walgreens Boots Alliance, and Cigna Corporation.

Polaris Market Research has segmented the e-pharmacy market research report on the basis of drug type, product type, payment method, platform, therapeutic area, business model, and region:

By Drug Type Outlook (Revenue - USD Billion, 2021-2034)

Prescription Drug

OTC Drug

By Product Type Outlook (Revenue - USD Billion, 2021-2034)

Skin Care

Dental

Cold and Flu

Vitamins

Weight Loss

Other Product Types

By Payment Method Outlook (Revenue - USD Billion, 2021-2034)

Cash On Delivery

Online Payment

By Platform Outlook (Revenue - USD Billion, 2021-2034)

App Based

Web Based

By Therapeutic Area Outlook (Revenue - USD Billion, 2021-2034)

Pain Management

Cardiovascular Diseases

Diabetes & Metabolic Disorders

Respiratory Disorders

Gastrointestinal (GI) Disorders

Dermatology

Women's Health

Mental Health

Others

By Business Model Outlook (Revenue - USD Billion, 2021-2034)

Inventory

Marketplace

Hybrid

By Regional Outlook (Revenue - USD Billion, 2021-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Vietnam

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Product Code: PM1012

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global E-Pharmacy Market Insights

4.1. E-Pharmacy Market - Distribution Channel Snapshot
4.2. E-Pharmacy Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing Prevalence of Chronic Illnesses
  - 4.2.1.2. Rising Government Initiatives
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Counterfeit Drugs and Illegal Online Pharmacies
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. E-Pharmacy Market Distribution Channel Trends
4.6. Value Chain Analysis

5. Global E-Pharmacy Market, by Drug Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
5.3. Prescription Drug
- 5.3.1. Global E-Pharmacy Market, by Prescription Drug, by Region, 2021-2034 (USD Billion)
5.4. OTC Drug
- 5.4.1. Global E-Pharmacy Market, by OTC Drug, by Region, 2021-2034 (USD Billion)

6. Global E-Pharmacy Market, by Product Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
6.3. Skin Care
- 6.3.1. Global E-Pharmacy Market, by Skin Care, by Region, 2021-2034 (USD Billion)
6.4. Dental
- 6.4.1. Global E-Pharmacy Market, by Dental, by Region, 2021-2034 (USD Billion)
6.5. Cold and Flu
- 6.5.1. Global E-Pharmacy Market, by Cold and Flu, by Region, 2021-2034 (USD Billion)
6.6. Vitamins
- 6.6.1. Global E-Pharmacy Market, by Vitamins, by Region, 2021-2034 (USD Billion)
6.7. Weight Loss
- 6.7.1. Global E-Pharmacy Market, by Weight Loss, by Region, 2021-2034 (USD Billion)
6.8. Other Product Types
- 6.8.1. Global E-Pharmacy Market, by Other Product Types, by Region, 2021-2034 (USD Billion)

7. Global E-Pharmacy Market, by Payment Method

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
7.3. Cash On Delivery
- 7.3.1. Global E-Pharmacy Market, by Cash On Delivery, by Region, 2021-2034 (USD Billion)
7.4. Online Payment
- 7.4.1. Global E-Pharmacy Market, by Online Payment, by Region, 2021-2034 (USD Billion)

8. Global E-Pharmacy Market, by Therapeutic Area

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
8.3. Pain Management
- 8.3.1. Global E-Pharmacy Market, by Pain Management, by Region, 2021-2034 (USD Billion)
8.4. Cardiovascular Diseases
- 8.4.1. Global E-Pharmacy Market, by Cardiovascular Diseases, by Region, 2021-2034 (USD Billion)
8.5. Diabetes & Metabolic Disorders
- 8.5.1. Global E-Pharmacy Market, by Diabetes & Metabolic Disorders, by Region, 2021-2034 (USD Billion)
8.6. Respiratory Disorders
- 8.6.1. Global E-Pharmacy Market, by Respiratory Disorders, by Region, 2021-2034 (USD Billion)
8.7. Other therapeutic areas
- 8.7.1. Global E-Pharmacy Market, by Other therapeutic areas, by Region, 2021-2034 (USD Billion)

9. Global E-Pharmacy Market, by Business Model

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
9.3. Inventory
- 9.3.1. Global E-Pharmacy Market, by Inventory, by Region, 2021-2034 (USD Billion)
9.4. Marketplace
- 9.4.1. Global E-Pharmacy Market, by Marketplace, by Region, 2021-2034 (USD Billion)
9.5. Hybrid
- 9.5.1. Global E-Pharmacy Market, by Hybrid, by Region, 2021-2034 (USD Billion)

10. Global E-Pharmacy Market, by Platform

10.1. Key Findings
10.2. Introduction
- 10.2.1. Global E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
10.3. App Based
- 10.3.1. Global E-Pharmacy Market, by App Based, by Region, 2021-2034 (USD Billion)
10.4. Web Based
- 10.4.1. Global E-Pharmacy Market, by Web Based, by Region, 2021-2034 (USD Billion)

11. Global E-Pharmacy Market, by Geography

11.1. Key Findings
11.2. Introduction
- 11.2.1. E-Pharmacy Market Assessment, By Geography, 2021-2034 (USD Billion)
11.3. E-Pharmacy Market - North America
- 11.3.1. North America: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
- 11.3.2. North America: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
- 11.3.3. North America: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
- 11.3.4. North America: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 11.3.5. North America: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
- 11.3.6. North America: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.3.7. E-Pharmacy Market - US
  - 11.3.7.1. US: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.3.7.2. US: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.3.7.3. US: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.3.7.4. US: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.3.7.5. US: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.3.7.6. US: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.3.8. E-Pharmacy Market - Canada
  - 11.3.8.1. Canada: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.3.8.2. Canada: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.3.8.3. Canada: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.3.8.4. Canada: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.3.8.5. Canada: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.3.8.6. Canada: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
11.4. E-Pharmacy Market - Europe
- 11.4.1. Europe: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
- 11.4.2. Europe: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
- 11.4.3. Europe: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
- 11.4.4. Europe: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 11.4.5. Europe: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
- 11.4.6. Europe: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.4.7. E-Pharmacy Market - UK
  - 11.4.7.1. UK: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.4.7.2. UK: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.4.7.3. UK: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.4.7.4. UK: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.4.7.5. UK: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.4.7.6. UK: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.4.8. E-Pharmacy Market - France
  - 11.4.8.1. France: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.4.8.2. France: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.4.8.3. France: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.4.8.4. France: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.4.8.5. France: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.4.8.6. France: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.4.9. E-Pharmacy Market - Germany
  - 11.4.9.1. Germany: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.4.9.2. Germany: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.4.9.3. Germany: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.4.9.4. Germany: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.4.9.5. Germany: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.4.9.6. Germany: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.4.10. E-Pharmacy Market - Italy
  - 11.4.10.1. Italy: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.4.10.2. Italy: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.4.10.3. Italy: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.4.10.4. Italy: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.4.10.5. Italy: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.4.10.6. Italy: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.4.11. E-Pharmacy Market - Spain
  - 11.4.11.1. Spain: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.4.11.2. Spain: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.4.11.3. Spain: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.4.11.4. Spain: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.4.11.5. Spain: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.4.11.6. Spain: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.4.12. E-Pharmacy Market - Netherlands
  - 11.4.12.1. Netherlands: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.4.12.2. Netherlands: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.4.12.3. Netherlands: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.4.12.4. Netherlands: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.4.12.5. Netherlands: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.4.12.6. Netherlands: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.4.13. E-Pharmacy Market - Russia
  - 11.4.13.1. Russia: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.4.13.2. Russia: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.4.13.3. Russia: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.4.13.4. Russia: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.4.13.5. Russia: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.4.13.6. Russia: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.4.14. E-Pharmacy Market - Rest of Europe
  - 11.4.14.1. Rest of Europe: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.4.14.2. Rest of Europe: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.4.14.3. Rest of Europe: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.4.14.4. Rest of Europe: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.4.14.5. Rest of Europe: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.4.14.6. Rest of Europe: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
11.5. E-Pharmacy Market - Asia Pacific
- 11.5.1. Asia Pacific: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
- 11.5.2. Asia Pacific: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
- 11.5.3. Asia Pacific: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
- 11.5.4. Asia Pacific: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 11.5.5. Asia Pacific: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
- 11.5.6. Asia Pacific: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.5.7. E-Pharmacy Market - China
  - 11.5.7.1. China: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.5.7.2. China: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.5.7.3. China: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.5.7.4. China: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.5.7.5. China: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.5.7.6. China: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.5.8. E-Pharmacy Market - India
  - 11.5.8.1. India: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.5.8.2. India: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.5.8.3. India: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.5.8.4. India: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.5.8.5. India: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.5.8.6. India: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.5.9. E-Pharmacy Market - Malaysia
  - 11.5.9.1. Malaysia: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.5.9.2. Malaysia: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.5.9.3. Malaysia: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.5.9.4. Malaysia: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.5.9.5. Malaysia: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.5.9.6. Malaysia: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.5.10. E-Pharmacy Market - Japan
  - 11.5.10.1. Japan: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.5.10.2. Japan: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.5.10.3. Japan: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.5.10.4. Japan: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.5.10.5. Japan: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.5.10.6. Japan: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.5.11. E-Pharmacy Market - Indonesia
  - 11.5.11.1. Indonesia: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.5.11.2. Indonesia: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.5.11.3. Indonesia: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.5.11.4. Indonesia: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.5.11.5. Indonesia: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.5.11.6. Indonesia: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.5.12. E-Pharmacy Market - South Korea
  - 11.5.12.1. South Korea: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.5.12.2. South Korea: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.5.12.3. South Korea: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.5.12.4. South Korea: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.5.12.5. South Korea: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.5.12.6. South Korea: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.5.13. E-Pharmacy Market - Australia
  - 11.5.13.1. Australia: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.5.13.2. Australia: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.5.13.3. Australia: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.5.13.4. Australia: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.5.13.5. Australia: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.5.13.6. Australia: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.5.14. E-Pharmacy Market - Rest of Asia Pacific
  - 11.5.14.1. Rest of Asia Pacific: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.5.14.2. Rest of Asia Pacific: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.5.14.3. Rest of Asia Pacific: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.5.14.4. Rest of Asia Pacific: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.5.14.5. Rest of Asia Pacific: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.5.14.6. Rest of Asia Pacific: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
11.6. E-Pharmacy Market - Middle East & Africa
- 11.6.1. Middle East & Africa: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
- 11.6.2. Middle East & Africa: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
- 11.6.3. Middle East & Africa: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
- 11.6.4. Middle East & Africa: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 11.6.5. Middle East & Africa: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
- 11.6.6. Middle East & Africa: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.6.7. E-Pharmacy Market - Saudi Arabia
  - 11.6.7.1. Saudi Arabia: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.6.7.2. Saudi Arabia: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.6.7.3. Saudi Arabia: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.6.7.4. Saudi Arabia: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.6.7.5. Saudi Arabia: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.6.7.6. Saudi Arabia: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.6.8. E-Pharmacy Market - UAE
  - 11.6.8.1. UAE: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.6.8.2. UAE: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.6.8.3. UAE: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.6.8.4. UAE: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.6.8.5. UAE: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.6.8.6. UAE: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.6.9. E-Pharmacy Market - Israel
  - 11.6.9.1. Israel: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.6.9.2. Israel: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.6.9.3. Israel: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.6.9.4. Israel: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.6.9.5. Israel: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.6.9.6. Israel: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.6.10. E-Pharmacy Market - South Africa
  - 11.6.10.1. South Africa: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.6.10.2. South Africa: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.6.10.3. South Africa: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.6.10.4. South Africa: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.6.10.5. South Africa: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.6.10.6. South Africa: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.6.11. E-Pharmacy Market - Rest of Middle East & Africa
  - 11.6.11.1. Rest of Middle East & Africa: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.6.11.2. Rest of Middle East & Africa: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.6.11.3. Rest of Middle East & Africa: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.6.11.4. Rest of Middle East & Africa: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.6.11.5. Rest of Middle East & Africa: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.6.11.6. Rest of Middle East & Africa: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
11.7. E-Pharmacy Market - Latin America
- 11.7.1. Latin America: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
- 11.7.2. Latin America: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
- 11.7.3. Latin America: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
- 11.7.4. Latin America: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
- 11.7.5. Latin America: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
- 11.7.6. Latin America: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.7.7. E-Pharmacy Market - Mexico
  - 11.7.7.1. Mexico: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.7.7.2. Mexico: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.7.7.3. Mexico: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.7.7.4. Mexico: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.7.7.5. Mexico: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.7.7.6. Mexico: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.7.8. E-Pharmacy Market - Brazil
  - 11.7.8.1. Brazil: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.7.8.2. Brazil: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.7.8.3. Brazil: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.7.8.4. Brazil: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.7.8.5. Brazil: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.7.8.6. Brazil: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.7.9. E-Pharmacy Market - Argentina
  - 11.7.9.1. Argentina: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.7.9.2. Argentina: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.7.9.3. Argentina: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.7.9.4. Argentina: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.7.9.5. Argentina: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.7.9.6. Argentina: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)
- 11.7.10. E-Pharmacy Market - Rest of Latin America
  - 11.7.10.1. Rest of Latin America: E-Pharmacy Market, by Drug Type, 2021-2034 (USD Billion)
  - 11.7.10.2. Rest of Latin America: E-Pharmacy Market, by Product Type, 2021-2034 (USD Billion)
  - 11.7.10.3. Rest of Latin America: E-Pharmacy Market, by Payment Method, 2021-2034 (USD Billion)
  - 11.7.10.4. Rest of Latin America: E-Pharmacy Market, by Therapeutic Area, 2021-2034 (USD Billion)
  - 11.7.10.5. Rest of Latin America: E-Pharmacy Market, by Business Model, 2021-2034 (USD Billion)
  - 11.7.10.6. Rest of Latin America: E-Pharmacy Market, by Platform, 2021-2034 (USD Billion)

12. Competitive Landscape

12.1. Expansion and Acquisition Analysis
- 12.1.1. Expansion
- 12.1.2. Acquisitions
12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

13.1. Express Scripts Holding
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Benchmarking
- 13.1.4. Recent Development
13.2. Giant Eagle
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Benchmarking
- 13.2.4. Recent Development
13.3. The Walgreen Company
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Benchmarking
- 13.3.4. Recent Development
13.4. Kroger Co
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Benchmarking
- 13.4.4. Recent Development
13.5. CVS Health Corporation
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Benchmarking
- 13.5.4. Recent Development
13.6. DocMorris
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Benchmarking
- 13.6.4. Recent Development
13.7. PharmEasy
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Benchmarking
- 13.7.4. Recent Development
13.8. Wal-Mart Stores
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Benchmarking
- 13.8.4. Recent Development
13.9. OptumRx
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Benchmarking
- 13.9.4. Recent Development
13.10. Rowland Pharmacy
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Benchmarking
- 13.10.4. Recent Development
13.11. Lloyds Pharmacy Ltd (McKesson Corporation)
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Benchmarking
- 13.11.4. Recent Development
13.12. Tata 1mg
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Benchmarking
- 13.12.4. Recent Development
13.13. Netmeds
- 13.13.1. Company Overview
- 13.13.2. Financial Performance
- 13.13.3. Product Benchmarking
- 13.13.4. Recent Development
13.14. Apollo Pharmacy
- 13.14.1. Company Overview
- 13.14.2. Financial Performance
- 13.14.3. Product Benchmarking
- 13.14.4. Recent Development
13.15. Amazon Pharmacy
- 13.15.1. Company Overview
- 13.15.2. Financial Performance
- 13.15.3. Product Benchmarking
- 13.15.4. Recent Development
13.16. Alibaba Health
- 13.16.1. Company Overview
- 13.16.2. Financial Performance
- 13.16.3. Product Benchmarking
- 13.16.4. Recent Development
13.17. JD Health
- 13.17.1. Company Overview
- 13.17.2. Financial Performance
- 13.17.3. Product Benchmarking
- 13.17.4. Recent Development
13.18. Walgreens Boots Alliance
- 13.18.1. Company Overview
- 13.18.2. Financial Performance
- 13.18.3. Product Benchmarking
- 13.18.4. Recent Development
13.19. Cigna Corporation
- 13.19.1. Company Overview
- 13.19.2. Financial Performance
- 13.19.3. Product Benchmarking
- 13.19.4. Recent Development